Savita Singh

发表

Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern

N. Gupta, A. Sette, D. Weiskopf, 2022, Nature Microbiology.

Activation of epigenetic regulator KDM6B by Salmonella Typhimurium enables chronic infections

Sarika Rana, P. Kshetrapal, D. Rathore, 2021, Gut microbes.

Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth

P. K. Garg, N. Sharma, D. Sok, 2022, bioRxiv.

Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months

P. K. Garg, Soonjyoti Das, B. Das, 2022, eBioMedicine.

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus

S. Bhattacharyya, Naveen Yadav, Rajesh Kumar, 2021, International Immunopharmacology.

Longitudinal Serology of SARS-CoV-2-Infected Individuals in India: A Prospective Cohort Study

N. Sharma, S. Bhatnagar, S. Saxena, 2021, medRxiv.

Nucleotide deletion in RHCE*cE (907delC) is responsible for a D– – haplotype in Hispanics

C. Westhoff, S. Vege, K. Hue‐Roye, 2011, Transfusion.

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

S. Bhattacharyya, A. Awasthi, J. Torres, 2021, bioRxiv.

A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation

R. Thiruvengadam, Rucha Chandwaskar, M. Gosain, 2024, NPJ vaccines.